These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25572573)

  • 61. Epigenetics: Cytosolic EZH1 muscles PRC2 out of the nucleus.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2017 May; 18(5):276-277. PubMed ID: 28377620
    [No Abstract]   [Full Text] [Related]  

  • 62. A BAF'ling Approach to Curing HIV.
    Tomar S; Ali I; Ott M
    Cell Chem Biol; 2018 Dec; 25(12):1441-1442. PubMed ID: 30576660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SnapShot: small RNA-mediated epigenetic modifications.
    Bei Y; Pressman S; Carthew R
    Cell; 2007 Aug; 130(4):756. PubMed ID: 17719551
    [No Abstract]   [Full Text] [Related]  

  • 64. Human immunodeficiency virus (HIV)-1 integration sites in viral latency.
    Rezaei SD; Cameron PU
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):88-96. PubMed ID: 25573791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir.
    Sung JA; Lam S; Garrido C; Archin N; Rooney CM; Bollard CM; Margolis DM
    J Infect Dis; 2015 Jul; 212(2):258-63. PubMed ID: 25589335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Understanding HIV latency: the road to an HIV cure.
    Dahabieh MS; Battivelli E; Verdin E
    Annu Rev Med; 2015; 66():407-21. PubMed ID: 25587657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Select host restriction factors are associated with HIV persistence during antiretroviral therapy.
    Abdel-Mohsen M; Wang C; Strain MC; Lada SM; Deng X; Cockerham LR; Pilcher CD; Hecht FM; Liegler T; Richman DD; Deeks SG; Pillai SK
    AIDS; 2015 Feb; 29(4):411-20. PubMed ID: 25602681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bioinformatics and HIV latency.
    Ciuffi A; Mohammadi P; Golumbeanu M; di Iulio J; Telenti A
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):97-106. PubMed ID: 25586146
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The integrase cofactor LEDGF/p75 associates with Iws1 and Spt6 for postintegration silencing of HIV-1 gene expression in latently infected cells.
    Gérard A; Ségéral E; Naughtin M; Abdouni A; Charmeteau B; Cheynier R; Rain JC; Emiliani S
    Cell Host Microbe; 2015 Jan; 17(1):107-17. PubMed ID: 25590759
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV-1 integration landscape during latent and active infection.
    Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC
    Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
    Kaczmarek Michaels K; Natarajan M; Euler Z; Alter G; Viglianti G; Henderson AJ
    J Immunol; 2015 Apr; 194(7):3267-74. PubMed ID: 25710909
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV Latency and the noncoding RNA therapeutic landscape.
    Saayman S; Roberts TC; Morris KV; Weinberg MS
    Adv Exp Med Biol; 2015; 848():169-89. PubMed ID: 25757621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A hardwired HIV latency program.
    Razooky BS; Pai A; Aull K; Rouzine IM; Weinberger LS
    Cell; 2015 Feb; 160(5):990-1001. PubMed ID: 25723172
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses.
    Wei W; Yu XF
    Cell Host Microbe; 2015 Jan; 17(1):8-9. PubMed ID: 25590755
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Double trouble: HIV latency and CTL escape.
    Marsden MD; Zack JA
    Cell Host Microbe; 2015 Feb; 17(2):141-2. PubMed ID: 25674977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An evolutionary role for HIV latency in enhancing viral transmission.
    Rouzine IM; Weinberger AD; Weinberger LS
    Cell; 2015 Feb; 160(5):1002-1012. PubMed ID: 25723173
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
    Laird GM; Bullen CK; Rosenbloom DI; Martin AR; Hill AL; Durand CM; Siliciano JD; Siliciano RF
    J Clin Invest; 2015 May; 125(5):1901-12. PubMed ID: 25822022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?
    Abbas W; Tariq M; Iqbal M; Kumar A; Herbein G
    Viruses; 2015 Mar; 7(4):1578-98. PubMed ID: 25835530
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.
    Chavez L; Calvanese V; Verdin E
    PLoS Pathog; 2015 Jun; 11(6):e1004955. PubMed ID: 26067822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.
    Fukazawa Y; Lum R; Okoye AA; Park H; Matsuda K; Bae JY; Hagen SI; Shoemaker R; Deleage C; Lucero C; Morcock D; Swanson T; Legasse AW; Axthelm MK; Hesselgesser J; Geleziunas R; Hirsch VM; Edlefsen PT; Piatak M; Estes JD; Lifson JD; Picker LJ
    Nat Med; 2015 Feb; 21(2):132-9. PubMed ID: 25599132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.